The Danish pharmaceutical company needs to move at a faster pace if it is to compete with Roche’s blockbuster Hemlibra for younger patients with hemophilia. But Novo Nordisk has one advantage.
发布者:BY IDA JORGENSEN,转转请注明出处:https://robotalks.cn/novo-nordisk-struggles-in-hemophilia-competition-with-roche/